2012

Multidisciplinary Management of Rectal Cancer

Questions and Answers

ISBN: 978-3-642-25004-0 (Print) 978-3-642-25005-7 (Online)

Table of contents (36 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xii

  2. Introduction

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-8

      What Do We Consider Cancer of the Rectum?

    3. No Access

      Book Chapter

      Pages 9-18

      What Is the Ongoing Recommendation in the Management of Rectal Cancer?

  3. Q&As on Risk Factor Identification

    1. Front Matter

      Pages 19-19

    2. No Access

      Book Chapter

      Pages 21-26

      What Prognostic Clinical Factors Must Be Considered Before Treatment?

    3. No Access

      Book Chapter

      Pages 27-39

      What Are the Relevant Imaging Factors to Optimize Treatment Decisions?

    4. No Access

      Book Chapter

      Pages 41-48

      What Biochemical and Molecular Biological Factors Have Greater Relevance to Treatment Decisions?

    5. No Access

      Book Chapter

      Pages 49-55

      Do Different Populations of Rectal Cancer Exist?

  4. Q&As on Imaging

    1. Front Matter

      Pages 57-57

    2. No Access

      Book Chapter

      Pages 59-65

      How Can We Identify Tumour Penetration?

    3. No Access

      Book Chapter

      Pages 67-71

      How Can We Identify Mesorectal Fascia Involvement?

    4. No Access

      Book Chapter

      Pages 73-75

      How Can We Identify Nodal Involvement?

    5. No Access

      Book Chapter

      Pages 77-93

      How Can We Identify Pathologic Complete Responders After Radiochemotherapy?

    6. No Access

      Book Chapter

      Pages 95-102

      How Can We Identify Local Relapse?

  5. Q&As on Radiotherapy

    1. Front Matter

      Pages 103-103

    2. No Access

      Book Chapter

      Pages 105-116

      When Should Preoperative Short-Course Radiotherapy or Long-Course Chemoradiotherapy Be Performed?

    3. No Access

      Book Chapter

      Pages 117-127

      Should We Tailor the Delineation of Pelvic Structures According to Tumor Presentation?

    4. No Access

      Book Chapter

      Pages 129-148

      What Is the Role of IMRT and IGRT in Rectal Cancer?

    5. No Access

      Book Chapter

      Pages 149-154

      What Are the Dose-Volume Constraints to Reduce Late Toxicity?

    6. No Access

      Book Chapter

      Pages 155-161

      What Is the Contribution of Intraoperative Radiotherapy (IORT) in Tailoring Local Therapy in Primary or Recurrent Rectal Cancer?

    7. No Access

      Book Chapter

      Pages 163-169

      What Is the Contribution of Brachytherapy in Tailoring Local Therapy?

  6. Q&As on Chemotherapy

    1. Front Matter

      Pages 171-171

    2. No Access

      Book Chapter

      Pages 173-179

      Should Oxaliplatin Be Added to Preoperative Chemoradiation?

    3. No Access

      Book Chapter

      Pages 181-191

      Should Biologic Targeted Agents Be Combined with Preoperative Chemoradiation in Rectal Cancer?

    4. No Access

      Book Chapter

      Pages 193-203

      Should Upfront Chemotherapy Precede Preoperative Chemoradiation and Surgery?

previous Page of 2